Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$7.4M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 2 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 19 most recent Form 4 transactions.
| Jul 1 | SYRE | Spyre Therapeutics, Inc. | SSELL◷ | 6,500 | $87.52 | $568.9K | -78.0% | Open the original filing on SEC.gov |
| Jul 1 | SYRE | Spyre Therapeutics, Inc. | MEXER◷ | 8,334 | $27.46 | $228.9K | — | Open the original filing on SEC.gov |
| Jun 3 | SYRE | Spyre Therapeutics, Inc. | MEXER◷◆ | 8,333 | — | — | — | Open the original filing on SEC.gov |
| Jun 3 | SYRE | Spyre Therapeutics, Inc. | SSELL◷ | 8,333 | $75.00 | $625K | -100.0% | Open the original filing on SEC.gov |
| Jun 3 | SYRE | Spyre Therapeutics, Inc. | MEXER◷ | 8,333 | $27.46 | $228.8K | — | Open the original filing on SEC.gov |
| May 1 | SYRE | Spyre Therapeutics, Inc. | MEXER◷◆ | 78,333 | — | — | — | Open the original filing on SEC.gov |
| May 1 | SYRE | Spyre Therapeutics, Inc. | SSELL◷ | 400 | $75.37 | $30.1K | -100.0% | Open the original filing on SEC.gov |
| May 1 | SYRE | Spyre Therapeutics, Inc. | SSELL◷ | 5,059 | $74.60 | $377.4K | -92.7% | Open the original filing on SEC.gov |
| May 1 | SYRE | Spyre Therapeutics, Inc. | SSELL◷ | 10,358 | $73.74 | $763.8K | -65.5% | Open the original filing on SEC.gov |
| May 1 | SYRE | Spyre Therapeutics, Inc. | SSELL◷ | 12,777 | $72.94 | $932K | -44.7% | Open the original filing on SEC.gov |
| May 1 | SYRE | Spyre Therapeutics, Inc. | SSELL◷ | 8,777 | $71.56 | $628.1K | -23.5% | Open the original filing on SEC.gov |
| May 1 | SYRE | Spyre Therapeutics, Inc. | SSELL◷ | 19,656 | $70.61 | $1.4M | -34.5% | Open the original filing on SEC.gov |
| May 1 | SYRE | Spyre Therapeutics, Inc. | SSELL◷ | 21,306 | $69.53 | $1.5M | -27.2% | Open the original filing on SEC.gov |
| May 1 | SYRE | Spyre Therapeutics, Inc. | MEXER◷ | 78,333 | $27.46 | $2.2M | — | Open the original filing on SEC.gov |
| Apr 1 | SYRE | Spyre Therapeutics, Inc. | MEXER◷◆ | 7,958 | — | — | — | Open the original filing on SEC.gov |
| Apr 1 | SYRE | Spyre Therapeutics, Inc. | SSELL◷ | 7,958 | $50.00 | $397.9K | -100.0% | Open the original filing on SEC.gov |
| Apr 1 | SYRE | Spyre Therapeutics, Inc. | MEXER◷ | 7,958 | $21.66 | $172.4K | — | Open the original filing on SEC.gov |